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Abstract: Marine microalgae have been used for a long time as food for humans, such as 
Arthrospira (formerly, Spirulina), and for animals in aquaculture. The biomass of these 
microalgae and the compounds they produce have been shown to possess several 
biological applications with numerous health benefits. The present review puts up-to-date 
the research on the biological activities and applications of polysaccharides, active 
biocompounds synthesized by marine unicellular algae, which are, most of the times, 
released into the surrounding medium (exo- or extracellular polysaccharides, EPS). It goes 
through the most studied activities of sulphated polysaccharides (sPS) or their derivatives, 
but also highlights lesser known applications as hypolipidaemic or hypoglycaemic, or as 
biolubricant agents and drag-reducers. Therefore, the great potentials of sPS from marine 
microalgae to be used as nutraceuticals, therapeutic agents, cosmetics, or in other areas, 
such as engineering, are approached in this review. 
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1. Introduction 
Besides being one of the richest sources of proteins, some species of microalgae/cyanobacteria 
produce other value-added compounds, such as polyunsaturated fatty acids (PUFAs), carotenoids, 
phycobiliproteins, polysaccharides, vitamins, or sterols. Other microalgae are high producers of 
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hydrocarbons, which can be converted into biodiesel or hydrogen that can be used as an alternative 
source of energy. Some of the produced PUFAs are essential ω-3 and ω-6 that can be included in 
functional, or nutraceutical foods, or as feed for chickens and cows, these, in turn, supplying eggs and 
milk enriched in those PUFAs. Other microalgae, or their derived-products, are used in the 
pharmaceutical industry, cosmetics, thalassotherapy, as biofertilizers, or as agents to fix soil particles, 
on golf-greens, as feed for animals, in aquaculture, or even in effluent treatments. 
Arthrospira, for example, is a promising cyanobacterium as it can be used in applications to lower 
hyperlipidaemia, hyperglycaemia, and hypertension, to protect against renal failure, and to promote 
growth of intestinal Lactobacillus [1–3]. Amongst other species of microalgae, marine strains of 
Chaetoceros, Isochrysis, Nannochloropsis, Pavlova, Phaeodactylum, Skeletonema, Thalassiosira and 
Tetraselmis, are the most frequently used in animal nutrition [1,4–6], especially due to their protein 
content, but also because they are particularly rich in essential lipids, namely ω-3 and ω-6 fatty acids 
(Table 1). Nevertheless, as microalgae differ in composition, they may have a better application when 
mixed, thus providing a balanced nutrition. 
Table 1. Applications of marine microalgae biomass, as such, or as extracts. 
Microalgae/Cyanobacteria Applications Main Effects/Type of Action References 
Arthrospira/Spirulina 
human nutrition/health food; liquid 
CO2 extracts (capsules); potential 
therapeutic 
prebiotic food; antioxidant 




human nutrition/health food and 
drink supplement; biofertilizer; 
effluent treatment 
growth factor (drink) [7,10–12] 
Chlorella stigmatophora; 
Phaeodactylum tricornutum 
potential therapeutic (hydrosoluble 
extract) 
anti-inflammatory, analgesic, 
free radical scavenging 
[13] 
Tetraselmis; Pavlova lutheri 





food for bivalves/shellfish larvae 




Nannochloropsis feed in aquaculture  [7] 
Dunaliella 
human nutrition (powder); oil 












In addition, some extracts of marine microalgae showed to have inhibitory effects on the activation 
of hyaluronidase, suggesting including anti-allergic and anti-inflammatory substances [8]. Therefore, 
some applications as therapeutic agents can be found for these microalgae. Furthermore, extracts of 
diatoms and C. stigmatophora were found to have antimicrobial properties [16] but have also shown 
activity profiles on the central nervous system, identical to that of neuroleptics [17,18]. Villar and  
co-workers [19] reported spasmolytic activity of the extracts of Phaeodactylum tricornutum in isolated 
non-vascular smooth muscle organs, and Laguna et al. [20] also referred to its anticoagulant capacity, 
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inhibiting ADP-induced aggregation of rat platelets. In other studies, extracts of P. tricornutum and  
C. stigmatophora significantly reduced paw-oedema in rats [13], thus suggesting the possession of 
anti-inflammatory properties. These researchers also found that tested extracts of the marine 
microalgae showed some analgesic and antioxidant activities (Table 1). 
Rasmussen and Morrissey [10] presented a fairly complete review on the food ingredients produced 
by marine organisms, where they also highlighted some of the applications of microalgae and/or their 
bioactive compounds, such as vitamins, pigments, fatty acids and other kinds of lipids, and  
other substances. 
Some of the marine/brackish species that are already commercially cultivated are Dunaliella salina, 
Isochrysis galbana, Nannochloropsis salina, Phaeodactylum tricornutum, Porphyridium cruentum, 
Arthrospira (Spirulina) platensis (cyanobacterium), among many others, most of them belonging  
to the Classes Bacillaryophyceae (diatoms), Chlorophyceae, Cyanophyceae (cyanobacteria), and 
Porphyridiophyceae (classis nova [21]). 
In order for these species to be commercially explored, several factors must be considered including 
their great diversity and ubiquity, and also the diversity of their chemical composition. In addition, 
genetic manipulation/improvement may be considered, as well as technologies used for large-scale 
cultivation and production. 
Besides these considerations, marine microalgae/cyanobacteria (hereafter referred to as microalgae) are 
easily produced, needing only a simple culture medium with seawater, a source of nitrogen, phosphate, 
iron, magnesium, and some minor salts. They do not need soil to be produced; some strains are 
extremophyles to temperature, salt or pH; they can be grown in closed bioreactors, combining sterile 
and controlled growth conditions. By controlling these growth conditions, different valuable products 
can be obtained. 
2. The Polysaccharides from Marine Microalgae: from the Sources to the Applications 
As happens with many species of seaweeds, the interest in marine microalgae is growing 
increasingly, especially because of the compounds they produce. An advantage of working with 
microalgae is the fact that they are easy to grow and culturing, and harvesting does not depend on the 
climate or season. Being easily controlled, it enables the production of polysaccharides, or whichever 
other compounds with similar properties, either chemical or physical, all year. Polysaccharides in 
general, and sulphated exopolysaccharides in particular, are released by many species of microalgae 
(Table 2) and the following applications have been found: They serve as antiviral agents (Table 3), 
health foods, antioxidants, they have anti-inflammatory properties and have a role in the 
immunomodulatory system, and they may also be used as lubricants for bone joints, or even as  
drag-reducing substances for ships (Table 4). 
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Table 2. Marine species of marine microalgae producing EPS. 
Microalgae/Cyanobacteria Group Type of Polysaccharide Main Sugars References 
Cylindrotheca closterium diatoms sPS xylose, glucose [22,23] 
Navicula salinarum  sPS glucose, xylose  
Phaeodactylum tricornutum  EPS (sulphated) glucose, mannose [24,25] 
Haslea ostrearia  EPS  [26] 
Nitzschia closterium  EPS  [27] 
Skeletonema costatum  EPS   
Chaetoceros sp.  EPS   
Amphora sp.  EPS  [25] 
Chlorella stigmatophora chlorophytes PS (sulphated) glucose, xylose [28] 
Chlorella sp.  sPS  [25,29,30] 
C. autotrophica  sPS   








sPS   
Porphyridium sp. rhodophytes sPS xylose, galactose [31–33] 
P. cruentum  sPS xylose, galactose [30,34,35] 
P. purpureum  sPS  [36] 
Rhodella reticulata  sPS xylose, galactose [31,32] 
Cochlodinium polykrikoides dinoflagellates sPS mannose, galactose [37] 
Gyrodinium impudicum  sPS galactose [38] 
Aphanothece halophytica cyanophytes EPS glucose, fucose [39] 
Arthrospira platensis  
sPS and intracellular 
sulphated calcium 
spirulan (CaSp) 
rhamnose, fructose [36,40,41] 
Anabaena, Aphanocapsa, Cyanothece, 
Gloethece, Nostoc, Phormidium, Synechocystis 
sPS  [42] 
EPS, exo- or extracellular polysaccharide; sPS, sulphate containing exopolysaccharide; PS, polysaccharide. 
2.1. Marine Unicellular Algae Producing EPS 
Marine microalgae that have been the targets of metabolites and/or exopolysaccharides studies are so 
diverse (Table 2) that it seems important to locate their taxonomic positions.  
All diatoms belong to the Class Bacillariophyceae, which includes organisms with round cells 
(Centrophycidae), and organisms with elongated cells (Pennatophycidae). Chaetoceros and 
Skeletonema belong to the first group; Amphora, Cylindrotheca, Haslea, Navicula, Nitzschia and 
Phaeodactylum are included in the second group. Isochrysis is a flagellated organism, belonging to the 
Class Prymnesiophyceae (or Haptophyceae). Prymnesiophyceae and Bacillariophyceae are two classes 
of the Phylum Chromophyta. 
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Table 3. Antiviral applications of EPS from marine microalgae. 
Microalgae/ 
Cyanobacteria 
Group Virus strain Family/Group of virus Cell-Lines EC50/ED50 (μg/mL) References 
A. platensis;  
A. maxima 
cyanobacteria 
vaccinia virus VACV and  
VACV-GFP; ectromelia virus (ECTV); 
HSV-1, HSV-2, human cytomegalovirus 













0.78; 69; 0.92–16.5; 
8.3–41; 17–39;  
23–92; 2.3–11.4;  
9.4–230 
[36,40,43,44] 
Porphyridium sp. rhodophytes 
herpes simplex virus HSV-1 and HSV-2; 
varicela zoster virus (VZV); murine 
sarcoma virus (MuSV-124) and 






1–5 (in vivo, 100); 
0.7; 10 and 5 (RT50) 
[45–47] 
P. cruentum  
hepatitis B virus (HBV); viral 
haemorrhagic septicaemia virus (VHSV); 
African swine fever virus (ASFV); 
vaccinia virus (VACV); vesicular 







20, 200 (exocellular 
extracts); 12–56;  
20–45 
[48–51] 
P. purpureum  
vaccinia virus VACV and VACV-GFP; 





R. reticulata  
herpes simplex virus HSV-1 and  
HSV-2; varicela zoster virus (VZV); 
murine sarcoma virus (MuSV-124) and 






10–20; 8; 150 and  
50 (RT50) 
[46,47] 
G. impudicum dinoflagellates 




MDCK 0.19–0.48 [52] 
C. polykrikoides  
Flu-A and Flu-B; respiratory syncytial 
virus type A (RSV-A) and B (RSV-B); 








0.45–1.1 and 7.1–8.3; 
2.0–3.0 and 0.8; 1.7; 
4.52–21.6; 0.8–25.3 
[37] 
EC50/ED50 is the concentration/dose at which 50% of the population exhibit a response after being exposed to a certain compound. 
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Table 4. Applications, other than antiviral uses, of EPS, from marine microalgae. 
Microalgae/Cyanobacteria Applications 
Cells/Animals used for  








antioxidant and free 
radical scavenging 
3T3; mouse liver homogenates and 
erythrocytes haemolysates, sarcoma  
180 cells/mice 
[55–58] 











dermal microvascular endothelial cells, 
humans; rabbits and sheep (bone joints); 
mice macrophages/mice and rats 
[28,55,62,63] 
Porphyridium, R. reticulata; 
Gyrodinium impudicum;  
A. platensis 
prevention of tumour 
cell growth 
FD early myeloid cell line, 24-1 and  
EL-4 T-lymphoma cell lines; Graff 
myeloid cells; rats 
[42,64–66] 
Phaeodactylum, Tetraselmis anti-adhesive HeLa S3/sand bass culture cells [30,67] 
Porphyridium biolubricant (for bone joints) [63,68] 
Porphyridium, R. reticulata ion exchanger  [69] 
P. cruentum, R. reticulata; 
R. maculata 
drag-reducers  [70,71] 
Another diverse group is Phylum Chlorophyta. Only two Classes were referred to in this work: 
Prasinophyceae, to which Tetraselmis belongs, and Chlorophyceae, which includes Chlorella and 
Ankistrodesmus, both Chlorococcales. 
Porphyridium and Rhodella are two genuses from the Phylum Rhodophyta. Porphyridium belongs 
to Class Porphyridiophyceae, Order Porphyridiales, and Family Porphyridiaceae; Rhodella is included 
in Class Rhodellophyceae, Order Rhodellales, and Family Rhodellaceae. However, there are still some 
organisms that have different scientific names, such as Dixionella grisea and Rhodella reticulata, and 
Porphyridium purpureum and P. cruentum. 
Both Cochlodinium and Gyrodinium are free dinoflagellates that belong to Phylum Pyrrophyta, 
Class Dynophyceae, and Order Gymnodiniales. 
Cyanophyta is a group of prokaryotic organisms, most of the times studied alongside with 
microalgae (eukaryotic organisms). This Phylum includes a Class, Cyanophyceae, with either 
filamentous or non-filamentous structures, a distinction of sub-classes being based on the hormogonia 
formation. Aphanocapsa, Aphanothece, Cyanothece, Gloeothece and Synechocystis do not form 
hormogonia and, therefore, they are included in the sub-Class Coccogonophycidae, Order 
Chroococcales. Anabaena, Arthrospira, Nostoc, and Phormidium belong to the sub-Class 
Hormogonophycidae, Order Nostocales/Oscillatoriales, whose filaments are not ramified or, if they 
present branches, these are false.  
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2.2. Structure and Rheology of the Exopolysaccharides 
In order to fully understand the different uses and applications of the extracellular polysaccharides, 
structure and physicochemical characteristics must be taken into account. These include the 
rheological properties, and molecular weight, as these parameters seem to be relevant to their function 
and behaviour. For example, as Geresh and co-workers reported, characterization of the EPS from 
Porphyridium depends on several factors, such as, the number of sugars, the resistance of the 
biopolymer to enzymatic digestion, the high molecular weight, and the viscosity, but also the tendency 
of particles to aggregate in solution [72]. 
Among the polysaccharides focused on in this study, only the sPS from Gyrodinium impudicum is a 
homopolymer of galactose [38]; the exocellular polysaccharides of all the other marine microalgae 
showed to be heteropolymers, constituted mainly of xylose, galactose, and glucose in different 
proportions (Table 2). Other sugars can also be part of the EPS composition, such as fucose, rhamnose, 
and fructose. 





), negatively charged (anionic), and sulphated heteropolysaccharides [72]. The high 
molecular weight is due to the ionic bridges formed through divalent cations [73]. A di-unit saccharide 
building block, an aldobiuronic acid, was found to be part of the constitution of the polymer [74]. The 
glucose and galactose of this disaccharide present their sulphate groups at positions three and six [69]. 
The percentages of sulphate residues are different between the sPS of the various strains of microalgae 
(Table 5). A common characteristic is the acidic character of these polymers, which is due to the 
presence of glucuronic acid and half-ester sulphate groups [59], these components, along with the 
carboxyl groups, also contribute to the anionic properties of the polysaccharides [69,74,75]. The presence 
of either a covalently bound protein [76] or a noncovalently bound glycoprotein [77,78], with different 
molecular weights, ≤10 kDa and 66 kDa, respectively, was also reported as being unique in the sPS 
from Porphyridium [78,79]. 
Table 5. Percentages of sulphate, protein, and uronic acids in polysaccharides from 
different marine microalgae. 
Microalgae/Cyanobacteria Sulphate (%) Protein (%) Uronic acids (%) References 
Porphyridium sp. 7.6–14.6 1–2 7.8–10 [31,55,80] 
Rhodella sp. 8 6 5–7.8 [31,81] 
A. platensis 5–20 6 7 [82] 
C. stigmatophora 7.8–9.4  3.7–9.0 [28] 
P. tricornutum 7.5–13.3  1.4–6.3 [28] 
C. closterium 0–10.9 7.7–9.2 4.8–21.0 [22] 
N. salinarum 6.3–11.5 0.5–4.9 7.7–8.0 [22] 
C. polykrikoides 7–8  presence, without % [37] 
G. impudicum 10.3  2.9 [38] 
According to Eteshola et al. [75], polysaccharide of Porphyridium is probably organized as a single 
two-fold helix, suggesting that the polymer contains large regions with a repeated chemical structure, 
which could be a disaccharide. The single helices of the sPS could even aggregate into several chains 
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due to the interactions between methyl groups of the sugar residues and the aminoacids of a (smaller) 
protein consisting of different chain molecules. This smaller protein moiety, which might be attached 
to the main polysaccharide chain of the biopolymer [75], could be the one that is covalently linked to  
the polysaccharide. 
Despite the existence of several marine species of microalgae producing exocellular polysaccharides 
with biological activities (Table 2), only a few of these polymers have been studied in relation to their 
biochemical composition and structure, and even less is known about the relationship between their 
conformation and structure, and their physicochemical properties, including rheological behaviour. 
These studies focused only on some species of marine unicellular red algae. 
Qualitatively, solutions of sPS from red microalgae, such as Porphyridium and Rhodella, are 
characterized by their non-Newtonian characteristics [31], pseudoplastic properties [55], and 
thixotrophic characteristics [75], evaluated (quantitatively) by their viscosity, elasticity, shear rate, 
shear strain, and shear stress [83]. It is well known that hydrocolloid solutions of sPS, produced by red 
microalgae and the cyanobacterium A. platensis, present a non-Newtonian behaviour, as their  
viscosity depends negatively on the shear strain rate, i.e., decreases with the increase of this last  
parameter [50,72,75,81,84,85], thus showing that it is a pseudoplastic compound [86] with a strong 
shear-thinning behaviour [75]. However, Sun et al. [58] showed that fragments of EPS from 
Porphyridium had a different rheological behaviour, depending on the degree of degradation, 
sometimes exhibiting typical characteristics of Newtonian fluids. In addition, elasticity, viscosity, and 
intrinsic viscosity decrease when high temperatures (>90 °C) are applied in the drying process of the 
EPS, as these high temperatures cause significant modifications in the conformation of the polymer 
chains [85]. Another reason supporting the idea of EPS from Porphyridium having weak-gel 
characteristics is the fact that elasticity (G′) values were higher than viscosity (G″) values after small 
deforming oscillatory forces were applied to the EPS, which had been dried at temperatures below  
140 °C [72,85]. These properties were also maintained when polysaccharide was obtained from 
cultures grown in different concentrations of sulphate [50]. This decrease in viscosity, with the 
application of higher shear rates, was suggested as being related to the dissociation of the strong 
hydrogen bonds that exist between polymer chains [85]. In this study, Ginzberg and co-workers [85] 
well described the influence of several factors in the conformational modifications, and also 
highlighted the effects caused by drying on the interactions between the polymer and its  
non-covalently linked glycoprotein. 
Furthermore, Eteshola and colleagues [75] presented a fairly complete study on the rheology of the 
EPS produced by red microalgae, including X-ray diffraction techniques, and referring also to the 
viscoelastic properties of the EPS through dynamic mechanical spectra. They observed, as well, an 
increase in the G’ modulus for temperatures above 60 °C, suggesting that heat promoted polymer  
self-association in an aqueous solution. 
2.3. Biological Activities and Applications 
There are extensive publications on the applications of microalgal biomass and biocompounds 
produced by microalgae, including literature on the antiviral activity of the polysaccharides produced by 
some microalgae, but little has been published in other areas and only dealing with a few marine species. 
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2.3.1. Antiviral Activity 
Many studies have already highlighted that the polysaccharides released to the culture medium by 
some marine microalgae present antiviral bioactivity against different kinds of viruses, either 
mammalian or otherwise (Table 3). Radonic et al. [36] and Chen et al. [56] have reviewed the antiviral 
effects of several sPS on different host cell-lines. Calcium-Spirulan, an intracellular polysaccharide 
produced by A. platensis, inhibited the replication of several viruses in vitro by inhibiting the 
penetration of the virus into the different host cells used [40,43]. Radonic and co-workers [36] also 
showed that the polysaccharide released into medium by A. platensis and P. purpureum exhibited 
antiviral activity in vitro and in vivo against two strains of Vaccinia virus and an Ectromelia virus. 
The antiviral activity is probably the most studied quality exhibited by sulphated polysaccharides of 
marine microalgae, especially that produced by Porphyridium. The mechanisms for this activity are 
not yet completely understood. As happens with heparin, the anionic nature of the sPS makes it a good 
candidate to protect against viruses. Several mechanisms have been proposed. Hayashi and  
colleagues [40] noted that sPS inhibited infection by different viruses by inhibiting the penetration of 
viral particles into host cells, but other mechanisms can also be the involved, such as the inhibition of 
attachment/adsorption, or even replication during the early phases of the virus cycle [41,87], without 
any toxicity to the host cells [37]. 
2.3.2. Activity as Antioxidants and Free Radical Scavenging 
While photoautotrophs, microalgae/cyanobacteria are highly exposed to oxidative and radical 
stresses, therefore accumulating effective anti-oxidative scavenger complexes to protect their own cells 
from free radicals [7]. Oxidation of lipids by reactive oxygen species (ROS), like hydroxyl radicals, 
hydrogen peroxide, and superoxide anion, can affect the safety of pharmaceuticals and also decrease 
the nutritional quality of foods. 
Sulphate polysaccharides released by marine microalgae may not only function as dietary  
fibre [54], but have also demonstrated the ability to prevent the accumulation and the activity of free 
radicals and reactive chemical species, therefore, acting as protecting systems against these oxidative 
and radical stress agents (Table 4). According to Tannin-Spitz et al. [57], the sPS from Porphyridium 
exhibited antioxidant activity against the autooxidation of linoleic acid, and inhibited oxidative damage 
to 3T3 cells that might be caused by FeSO4. They demonstrated that bioactivity was dose-dependent, 
correlating positively with sulphate content of the sPS, and referred to the possibility of the 
glycoprotein to contribute to the antioxidant properties. It was even suggested that the antioxidant 
activity of this polymer relied on its ability to act as a free radical scavenger [57]. Sun et al. [58] 
prepared different molecular-weight polysaccharide-derived products of P. cruentum, using a 
hermetical microwave technique, and found that the lower molecular-weight fragments  
(6.55–256 kDa) showed higher antioxidant activity, better protecting mouse cells and tissues from 
oxidative damage by inhibiting lipid peroxidation induced by FeSO4 and ascorbic acid. Free radical 
scavenging of some of the EPS fragments was significantly higher at the same, or even lower, 
concentration than that reported previously for vitamin C [88]. But strangely, they found no 
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scavenging activity and no inhibition of oxidative damage in cells and tissues for the crude high 
molecular sPS from Porphyridium cruentum [58]. 
Sulphated exopolysaccharide from Rhodella reticulata also showed to have antioxidant activity, the 
effects being dose-dependent [56]. Unlike what happens with the sPS from Porphyridium [58], crude 
sPS from Rhodella exhibited higher antioxidant properties than the polysaccharide-modified samples, 
these demonstrating lower radicals scavenging activity [56]. These researchers found that all the 
different samples of sPS from R. reticulata had a stronger ability against superoxide anion radical 
scavenging than α-tocopherol, the crude polysaccharide being twice as strong as α-tocopherol. 
2.3.3. Anti-Inflammatory and Immunomodulatory Activities 
Polysaccharides from marine microalgae, like Porphyridium, Phaeodactylum, and Chlorella 
stigmatophora, were found to show pharmacological activities, such as anti-inflammatory activity and 
as immunomodulatory agents (Table 4). Direct stimulatory effect of Phaeodactylum tricornutum on 
the immune cells was evidenced by the positive phagocytic activity assayed either in vitro or in vivo, 
and the activity of the extract of sPS from C. stigmatophora showed immunosuppressant effects [28]. 
As reported for the polysaccharide from Ulva rigida, a green seaweed [89], the sPS p-KG03 from the 
marine dinoflagellate G. impudicum also activates the production of nitric oxide and immunostimulates the 
production of cytokines in macrophages [90]. However, on the other hand, inhibition of leukocyte 
migration seems to be related to the anti-inflammatory activity of the polysaccharides [62]. As 
leukocyte movement to the site of injury contributes to additional cytokine release and production of 
nitric oxide, therapeutics has to be effective against this over-inflammation. Matsui and co-workers [62] 
found that sPS from Porphyridium is a good candidate for this role as it inhibited the movement and 
adhesion of polymorphonuclear leukocytes in vitro, and inhibited the development of erythema in vivo 
as well. 
When studying the effects of EPS-derived products, Sun [55] showed that EPS presented 
immunostimulating activity in mice with S180 tumours, by increasing both spleen and thymus index, 
and also spleen lymphocyte index. Smaller fragments of sPS have also demonstrated the capacity to 
improve the production of NO in mouse macrophages. In his Ph.D. Thesis, Sun [55] referred to the fact 
that sulphate content has a positive correlation with the immunomodulatory system. Further, 
Namikoshi [91] noted that sPS can stimulate the immune system by triggering cells and humour 
stimulation. This shows the capacity of marine unicellular algae sPS to directly stimulate the  
immune system. 
2.3.4. Inhibition of Tumour Cell Growth 
One potentially promising activity of polysaccharides is the ability to prevent tumour cell growth. 
The homopolysaccharide of G. impudicum, that has immunomodulatory properties, suppressed tumour 
cell growth, both in vitro and in vivo [91,92], by stimulating the innate immune system (Table 4).  
Calcium-Spirulan of Arhrospira (Spirulina) was reported to prevent pulmonary metastasis, also 
preventing the adhesion and proliferation of tumour cells. It is also promising in treating spinal cord 
injuries and as matrices for stem cell cultures [93]. 
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Geresh et al. [64] demonstrated that the high molecular weight oversulphated EPS from 
Porphyridium inhibited neoplastic mammalian cell growth, and Shopen-Katz et al. [66] had previously 
reported that biomass of this microalga could prevent the proliferation of colon cancer in rats. On the 
other hand, Sun [55] noted that non-modified or high molecular-weight fragments of sPS from  
P. cruentum showed no inhibition of tumour cell growth. Some smaller EPS-derivatives showed 
significant activity on Sarcoma 180 tumour cell proliferation in rats though. However, Geresh and  
co-workers [64] also found that the non-modified sPS had no significant inhibition at the same 
concentration as EPS-derivatives. Furthermore, in a recent study, Gardeva et al. [65] reported the 
strong anti-tumour activity exhibited by the polysaccharide of P. cruentum. They found that this 
sulphated polymer strongly inhibited Graffi myeloid tumour proliferation in vitro and in vivo, that the 
activity was dose-dependent, and that survival time of hamsters was enhanced in 10–16 days. Gardeva 
and co-workers [65] suggested that the anti-tumour activity could be related to its immunostimulating 
properties, and observed that EPS from Porphyridium could be a good candidate as an anticancer agent. 
2.3.5. Hypolipidaemic and Hypoglycaemic Properties 
Recently, Jiao et al. [94] reported in their review what was being done with sulphated 
polysaccharides produced by macroalgae, including the capacity of sPS to reduce total cholesterol and 
serum triglycerides (in rats). This is an area that has not been sufficiently explored in regards to 
microalgae (Table 4). However, when Ginzberg and co-workers fed chickens with biomass of 
Porphyridium with EPS, they found that cholesterol was reduced either in serum or egg yolk of 
chickens, modifying fatty acid profile, and improving carotenoid content in egg yolk as well [60]. In 
addition, rats fed with Porphyridium and R. reticulata biomass, the polysaccharides of which contain 
dietary fibres, showed a decrease in the serum cholesterol and triglycerides; hepatic cholesterol levels 
were also improved, the levels of VLDL had also considerably lowered, and no toxic effects were 
noticed in the animals [53,54,95]. Furthermore, Dvir and co-workers [95] also reported that rodents fed 
with Rhodella biomass presented lower levels of insulin and glucose. An experiment conducted by 
Huang and co-workers [61] also showed the capacity of sPS from Porphyridium to significantly lower 
glucose levels in the blood of diabetic mice, causing no modifications in the pancreatic island cells and 
no fibrosis, or haemorrhagic necrosis in cells, either. 
These experiments suggest the strong potential of sulphated polysaccharides to be used as 
hypolipidaemic and hypoglycaemic agents. They could also be used as sources of nutraceuticals due to 
their content in fibres, the ability of bile acid binding and cation exchange, and the properties of faecal 
bulking as well [53,54]. Sulphated polysaccharides from unicellular algae are also promising 
substances in reducing coronary heart disease, due to their hypocholesterolaemic effects [53,54]. 
Mechanisms involved in the role of dietary fibres, in lowering cholesterol, are not yet completely 
understood, but Oakenful [96] proposed that it could be related to the increase of the viscosity of the 
intestinal contents, which influences nutrient absorption, micelle formation, and decreasing lipid 
absorption. In addition, the decrease in serum cholesterol levels and the increase in bile excretion, 
caused by disruption of enterophatic circulation of bile acids, was suggested as another possible 
explanation [97,98]. 
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2.3.6. Anti-Adhesive Agents 
Sulphated polysaccharides from unicellular marine algae revealed the ability to block the adhesion 
of pathogenic microorganisms, which suggests the hypothesis to be used in anti-adhesive therapeutics. 
As a matter of fact, several sPS presented greater inhibition of the adherence of both  
Helicobacter pylori to HeLa S3 cell line and three fish pathogens to spotted sand bass gills, gut, and 
skin cultured cells [30] (Table 4). 
The major role of carbohydrates as recognition sites on the cell surfaces to which microorganisms can 
attach to, allowing infection, has already been evidenced [99]. Heparan sulphate glycosaminoglycan 
was identified as one of those receptors in host cells [100]. These researchers suggested that this 
interaction could be associated to the net charge and molecular stereochemistry of the polymer. 
Nevertheless, a therapy based on sulphated polysaccharides may have some risks; therefore, further 
studies are needed in order to know their cytotoxic and anticoagulant properties. 
2.3.7. Anticoagulant and Antithrombotic Activity 
There are several studies on the anticoagulants isolated from seaweeds (marine macroalgae), which 
are presented in a recent review by Wijesekara et al. [101], but only a few references on microalgae. 
On the one hand, it was stated that the anticoagulant activity is associated to the high sulphate content 
of the polysaccharides. However, this characteristic can be a problem when considering their use for 
the treatment of virus-induced diseases. On the other hand, Hasui et al. [37] found no anticoagulant 
activity in the sPS of Cochlodinium polykrikoides, in spite of the 7%–8% sulphate of the 
polysaccharide. This suggests that the anticoagulant properties of the polysaccharides do not depend 
only on the percentage of sulphate residues, but rather, mostly on the distribution/position of sulphate 
groups and probably on the configuration of the polymer chains, as it was stated by Ginzberg et al. [85] and 
Pereira et al. [102]. 
2.3.8. Biolubricant Properties 
This is one of the lesser known applications for the sPS and very little has been published on this 
issue (Table 4). Nevertheless, Arad et al. [68] have proved the superior biolubricant power of sPS 
from Porphyridium. Exocellular sulphated polysaccharide of Porphyridium has already shown good 
lubrication ability due to its rheological characteristics [103]. Arad and co-workers [68] prepared an 
experiment where the lubricating properties of sPS were compared to the most used hydrogel lubricant, 
hyaluronic acid. They simulated efforts of joints, both when walking and running, and found a better 
quality from the EPS from Porphyridium as its rheological characteristics showed to be stable at higher 
temperatures than most lubricants used, whose viscosity decreases along with a decrease of lubricity. 
These researchers also found that a 1% solution of polysaccharide presented the best friction properties 
under high loads, and its viscosity did not suffer any significant change when incubated with 
hyaluronidase, with standing degradation by this enzyme. This experiment shows the potential of sPS 
from Porphyridium to be an excellent candidate to substitute hyaluronic acid as a biolubricant. It may 
also be a promising substance to be part of joint-lubricating solutions, as was stated in the patent 
proposed by Arad and Atar [63], to mitigate degenerative joint disorders caused by arthritis. The 
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effects of the solutions containing EPS from Porphyridium were tested by injecting them into the joints 
of rabbits’ knees. 
2.3.9. Drag-Reducers 
Another little known field of application is as drag-reducers. Only a few studies were conducted in 
order to determine whether polysaccharides had the potential of drag-reducing, to broaden their 
functionalities for engineering applications (Table 4). The drag-reducing properties of polysaccharides 
were tested in some EPS from marine microalgae [71], but Gasljevic et al. [70] recently studied the 
potential of several marine microalgal polysaccharides as drag-reducers. P. cruentum and R. maculata 
were the ones whose polysaccharides showed the higher drag-reducing power at lower concentrations, 
followed by Schizochlamydella (former Chlorella) capsulata. These researchers found that to have the 
same level of drag-reduction effectiveness, 25% more polysaccharide of R. maculata is required than 
of P. cruentum, and almost three times as much as the polysaccharide of S. capsulata [70]. 
2.3.10. Other Applications 
As happens with polysaccharides from seaweeds [104,105], EPS from unicellular marine algae 
could also find some application in the health food industry, and in nutraceuticals and functional foods. 
Other areas, as diverse as cosmetics or as ion-exchangers, could also be possible due to the 
chemical composition and rheological characteristics of the marine microalgal sPS. 
Prophylactic therapy in microbial infections might also be a promising activity as exopolysaccharides 
from marine microalgae have already shown the ability to block microbial cytoadhesion to host cells [30] 
and to inhibit growth of Salmonella enteritidis [50]. 
Finally, besides all these applications, adhesion properties of the sPS produced by microalgae seem 
to play an important role in either the locomotion of some algae [106] or in the aggregation of soil and 
sand particles [107,108], influencing stability and cohesiveness of sediments. 
3. Final Remarks 
Sulphated exopolysaccharides synthesized by different marine microalgae are heterogeneous and 
structurally different, which makes research very challenging. Unlike seaweeds, microalgae can grow 
under controlled conditions making chemical composition, structure, and rheological behaviour of 
algal sPS more stable along the several harvesting periods. These polymers have already proved their 
beneficial effects but a lot is still to be done. For example, it would be interesting to explore its use 
orally, and therapeutically, in human subjects, considering their anti-inflammatory, hypoglycaemic, 
and anticoagulant/antithrombotic activities. However, the toxicity and bioavailability of such compounds 
are yet to be studied on humans. Challenging areas that may broaden applications of microalgal sPS 
are biomedical (as biolubricants), machine/mechanical or ship engineering (as drag-reducers), and food 
science/engineering, due to their rheological and biochemical characteristics. 
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